PSA density is associated with BPH cellular composition.

Jia, Liwei; Strand, Douglas W; Goueli, Ramy S; Gahan, Jeffrey C; Roehrborn, Claus G; Mauck, Ryan J

Jia, Liwei; Strand, Douglas W; Goueli, Ramy S; Gahan, Jeffrey C; Roehrborn, Claus G; Mauck, Ryan J.

Afiliación

Jia L; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA.
Strand DW; Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USA.
Goueli RS; Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USA.
Gahan JC; Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USA.
Roehrborn CG; Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USA.
Mauck RJ; Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USA.

Prostate ; 82(12): 1162-1169, 2022 09.

Article en En | MEDLINE | ID: mdl-35652548

Asunto(s)

Hiperplasia Prostática; Inhibidores de 5-alfa-Reductasa/uso terapéutico; Humanos; Masculino; Próstata/patología; Antígeno Prostático Específico; Hiperplasia Prostática/patología

Palabras clave

PSA density; benign prostatic hyperplasia; histology; prostate specific antigen; prostate volume

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hiperplasia Prostática Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Prostate Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google